Menu
Applications are now closed. Stay tuned for future opportunities!
Are you a startup or university-based project pioneering the future of therapeutics and vaccines? We’re looking for innovative solutions that align with BARDA’s mission to enhance pandemic preparedness and health security. Apply to the VITAL Biotech Accelerator Program and make a global impact!
Applications are now closed. Follow VITAL on LinkedIn to stay informed about future opportunities!
Receive highly individualized mentoring tailored to your company’s needs over the course of 6 months. Enjoy a flexible hybrid format and get paired with a lead mentor, project manager, and an extended team of subject matter experts.
Access a network of over 250 healthtech and biotech mentors, including entrepreneurs, development experts, investors, and clinicians – a diverse group of professionals dedicated to helping you succeed.
Connect with a global network of fellow entrepreneurs, customers, collaborators, and capital partners to accelerate your growth.
Join our accelerator without financial burden. Our program is entirely free, and we take no equity in your company, allowing you to retain full control and ownership of your innovation.
Submit your application before August 23 to enter to be selected for the milestone-based awards.
We will notify you by September 30 whether you have been selected to participate in the VITAL Biotech Accelerator Program.
Starting mid-October, you will begin your journey in the accelerator program, receiving tailored mentoring and access to our extensive network of experts.
Watch our info session to gain insights into the VITAL Biotech Accelerator Program and Funding opportunities.
Innovative vaccine and therapeutic technologies and platforms aligned with BARDA’s mission.
For more information on BARDA areas of interest, visit https://drive.hhs.gov/partner.html.
BARDA also recently released TPPs relevant to some of its areas of interest: https://medicalcountermeasures.gov/barda/tpp.
We are accepting applications from academic projects and innovators, as well as early-stage biotech companies globally, targeting the U.S., Europe, and Asia.
We are accepting applications from academic projects and innovators, as well as early-stage biotech companies globally, targeting the U.S., Europe, and Asia. Companies and individuals are welcome to apply for both the Accelerator Program and non-dilutive funding from VITAL. Applications will be reviewed independently. Solicitations for both the Accelerator Program and non-dilutive funding opportunities will be open on an annual basis.
Applications will be reviewed wholistically and comprehensively based on responses to the questions in the application.
Company or Individual Affiliations: Applications from companies or individual innovators from universities in the following countries will be subject to additional review: Afghanistan, Balkan countries, Burma, Central African Republic, Congo, Crimea and covered regions of Ukraine, Cuba, Ethiopia, Hong Kong, Iran, Iraq, Lebanon, Libya, Mali, Nicaragua, North Korea, Russia, Russian occupied Ukraine, Sudan, Syria, Venezuela, Yemen, and Zimbabwe.
The Accelerator Program is a 6-month long program, providing customized mentoring with subject matter experts on a bi-weekly meeting basis.
Each engagement starts with a Deep Dive – a multi-hour meeting with multiple subject matter experts. After the Deep Dive, each company or individual will work with their Lead Mentor to develop SMART goals and customized workstreams to provide support in areas such as fundraising, clinical-regulatory, product and platform development, and more. Each company or individual will then meet on a bi-weekly basis with their Lead Mentor, Project Manager, and other subject matter experts as needed. Every Lead Mentor, Project Manager, and other subject matter expert is under a Non-Disclosure Agreement (NDA).
Each company or individual is matched with a Lead Mentor and a Project Manager, who are both under a Non-Disclosure Agreement (NDA). The Lead Mentor will manage the engagement and will meet with the company or individual on a bi-weekly basis to provide support on topics such as fundraising, clinical-regulatory, product and platform development, and more. Other subject matter experts are also available as needed, all of whom are also under NDA.